199 related articles for article (PubMed ID: 14518204)
1. [Simultaneous immunocytochemical detection of tumor cells in lymph nodes and in bone marrow of patients with resectable bronchial carcinomas].
Passlick B; Pantel K; Kubuschok B; Izbicki JR; Thetter O
Langenbecks Arch Chir Suppl Kongressbd; 1998; 115(Suppl I):21-4. PubMed ID: 14518204
[TBL] [Abstract][Full Text] [Related]
2. [Limits of surgery in patients with apparently localized bronchial carcinoma (pT1-3, pN0, M0)].
Passlick B; Thetter O; Pantel K; Izbicki JR
Langenbecks Arch Chir Suppl Kongressbd; 1996; 113():779-84. PubMed ID: 9101989
[TBL] [Abstract][Full Text] [Related]
3. [The significance of regional lymphatic tumor cell dissemination in patients with resectable non-small cell bronchial carcinoma. Results of a prospective study].
Passlick B; Thetter O; Pantel K; Kubuschok B; Pichlmeier U; Schweiberer L; Izbicki JR
Chirurg; 1995 Aug; 66(8):780-5; discussion 785-6. PubMed ID: 7587541
[TBL] [Abstract][Full Text] [Related]
4. Detection of disseminated lung cancer cells in lymph nodes: impact on staging and prognosis.
Passlick B; Izbicki JR; Kubuschok B; Thetter O; Pantel K
Ann Thorac Surg; 1996 Jan; 61(1):177-82; discussion 183. PubMed ID: 8561549
[TBL] [Abstract][Full Text] [Related]
5. [Isolated tumor cells in bone marrow predicts reduced survival in lymph node-negative non-small-cell lung cancer].
Passlick B; Kubuschok B; Izbicki JR; Thetter O; Pantel K
Pneumologie; 2000 Aug; 54(8):355-60. PubMed ID: 11008478
[TBL] [Abstract][Full Text] [Related]
6. Do bone marrow isolated tumor cells influence long-term survival of non-small cell lung cancer?
Ruffato A; Mattioli S; Pileri S; Daddi N; D'Ovidio F; Pilotti V; Tazzari P
Eur J Cardiothorac Surg; 2009 Mar; 35(3):463-8. PubMed ID: 19150243
[TBL] [Abstract][Full Text] [Related]
7. Immunocytochemical detection of occult tumor cells in the bone marrow: prognostic impact on early stages of lung cancer.
Nosotti M; Tosi D; Palleschi A; Rosso L; Mendogni P; Santambrogio L
Eur Surg Res; 2008; 41(3):267-71. PubMed ID: 18594145
[TBL] [Abstract][Full Text] [Related]
8. Detection of disseminated colorectal cancer cells in lymph nodes, blood and bone marrow.
Weitz J; Kienle P; Magener A; Koch M; Schrödel A; Willeke F; Autschbach F; Lacroix J; Lehnert T; Herfarth C; von Knebel Doeberitz M
Clin Cancer Res; 1999 Jul; 5(7):1830-6. PubMed ID: 10430088
[TBL] [Abstract][Full Text] [Related]
9. Detection of disseminated tumor cells in mediastinoscopic lymph node biopsies and lymphadenectomy specimens of patients with NSCLC by quantitative RT-PCR.
Wang XT; Sienel W; Eggeling S; Ludwig C; Stoelben E; Mueller J; Klein CA; Passlick B
Eur J Cardiothorac Surg; 2005 Jul; 28(1):26-32. PubMed ID: 15939599
[TBL] [Abstract][Full Text] [Related]
10. [Surgical therapeutic strategy for non-small cell lung cancer with (N2) mediastinal lymph node metastasis].
Huang GJ; Fang DK; Cheng GY; Zhang DC
Zhonghua Zhong Liu Za Zhi; 2006 Jan; 28(1):62-4. PubMed ID: 16737625
[TBL] [Abstract][Full Text] [Related]
11. Immunocytological detection of bone marrow micrometastasis in operable non-small cell lung cancer.
Pantel K; Izbicki JR; Angstwurm M; Braun S; Passlick B; Karg O; Thetter O; Riethmüller G
Cancer Res; 1993 Mar; 53(5):1027-31. PubMed ID: 7679945
[TBL] [Abstract][Full Text] [Related]
12. Bone marrow and lymph node assessment for minimal residual disease in patients with breast cancer.
Diel IJ; Cote RJ
Cancer Treat Rev; 2000 Feb; 26(1):53-65. PubMed ID: 10660491
[TBL] [Abstract][Full Text] [Related]
13. [Multimodal treatment of non small cell lung cancer].
Stoelben E; Digel W; Henke M; Passlick B
Zentralbl Chir; 2006 Apr; 131(2):110-4. PubMed ID: 16612776
[TBL] [Abstract][Full Text] [Related]
14. Skip metastasis in nonsmall cell lung carcinoma: predictive markers and isolated tumor cells in N1 lymph nodes.
Prenzel KL; Baldus SE; Mönig SP; Tack D; Sinning JM; Gutschow CA; Grass G; Schneider PM; Dienes HP; Hölscher AH
Cancer; 2004 May; 100(9):1909-17. PubMed ID: 15112272
[TBL] [Abstract][Full Text] [Related]
15. Postoperative radiotherapy for stage II or III non-small-cell lung cancer using the surveillance, epidemiology, and end results database.
Lally BE; Zelterman D; Colasanto JM; Haffty BG; Detterbeck FC; Wilson LD
J Clin Oncol; 2006 Jul; 24(19):2998-3006. PubMed ID: 16769986
[TBL] [Abstract][Full Text] [Related]
16. [Prognostic factors in stage I of non-small-cell bronchial carcinoma].
Passlick B; Pantel K
Zentralbl Chir; 1996; 121(10):851-7; discussion 858-60. PubMed ID: 9019934
[TBL] [Abstract][Full Text] [Related]
17. Lymph node isolated tumor cells and micrometastases in pathological stage I non-small cell lung cancer: prognostic significance.
Rena O; Carsana L; Cristina S; Papalia E; Massera F; Errico L; Bozzola C; Casadio C
Eur J Cardiothorac Surg; 2007 Dec; 32(6):863-7. PubMed ID: 17936004
[TBL] [Abstract][Full Text] [Related]
18. The impact of multiple metastatic nodal stations on survival in patients with resectable N1 and N2 nonsmall-cell lung cancer.
Kang CH; Ra YJ; Kim YT; Jheon SH; Sung SW; Kim JH
Ann Thorac Surg; 2008 Oct; 86(4):1092-7. PubMed ID: 18805138
[TBL] [Abstract][Full Text] [Related]
19. Analysis of risk factors for skip lymphatic metastasis and their prognostic value in operated N2 non-small-cell lung carcinoma.
Benoit L; Anusca A; Ortega-Deballon P; Cheynel N; Bernard A; Favre JP
Eur J Surg Oncol; 2006 Jun; 32(5):583-7. PubMed ID: 16621424
[TBL] [Abstract][Full Text] [Related]
20. Postoperative radiotherapy for patients with completely resected pathological stage IIIA-N2 non-small cell lung cancer: focusing on an effect of the number of mediastinal lymph node stations involved.
Matsuguma H; Nakahara R; Ishikawa Y; Suzuki H; Inoue K; Katano S; Yokoi K
Interact Cardiovasc Thorac Surg; 2008 Aug; 7(4):573-7. PubMed ID: 18413349
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
